Canine cutaneous epitheliotropic T-cell lymphoma: A review

Veterinary and Comparative Oncology

Volumn 7, Issue 1, 2009, Pages 1-14

  Fontaine, Jacques ^a   Bovens, C ^a   Bettenay, S ^b   Mueller, R S ^c  

^a Service de Médecine interne des petits animaux Dermatologie   (Belgium)

^b Tierdermatologie Deisenhofen ^*  (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Comparative oncology; Cutaneous lymphoma; Epitheliotropic lymphoma; Mycosis fungoides; Small animal

Indexed keywords

ALKYLATING AGENT; LOMUSTINE;

ANIMAL; ANIMAL DISEASE; CUTANEOUS T CELL LYMPHOMA; DOG; DOG DISEASE; EPIDERMIS; FEMALE; HUMAN; MALE; PATHOLOGY; PROGNOSIS; REVIEW; SKIN TUMOR; T LYMPHOCYTE; TREATMENT OUTCOME;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; DOG DISEASES; DOGS; EPIDERMIS; FEMALE; HUMANS; LOMUSTINE; LYMPHOMA, T-CELL, CUTANEOUS; MALE; PROGNOSIS; SKIN NEOPLASMS; T-LYMPHOCYTES; TREATMENT OUTCOME;

ANIMALIA; CANIS FAMILIARIS;

EID: 65349137638     PISSN: 14765810     EISSN: 14765829     Source Type: Journal    
DOI: 10.1111/j.1476-5829.2008.00176.x     Document Type: Review

References (67)

1. Scott M. Muller and Kirk's Small Animal Dermatology, 6th edn., W.B. Saunders Company, 2001: 1330-1340.
2. Gross TL, Ihrke PJ, Walder EJ and Affolter VK. Skin Diseases of the Dog and Cat, Clinical and Histopathologic Diagnosis. 2nd edn., Oxford, Blackwell Science, 2005: 876-888.
3. Goldschmidt MH and Shofer FS. Skin Tumors of the Dog and Cat., Oxford, Pergamon Press, 1992: 252-264.
4. Campbell KL. Small Animal Dermatology Secrets., Urbana, IL, Hanley and Belfus, 2004: 431-441.
5. Alibert JL, ed. Description des maladies de la peau, observées à l'hôpital St-Louis et exposition des meilleurs méthodes suivies pour leur traitement. In: Tableau du Pian Fongoïde. Paris, Barrois L'Aine & Fils, 1806: 157.
6. Kelly DF, Halliwell REW and Schwartzman RM. Generalized cutaneous eruption in a dog with histological similarity to human mycosis fongoides. British Journal of Dermatology 1972; 86: 164-171.
7. Caciolo PL, Nesbitt GH, Patnaik AK and Hayes AA. Cutaneous lymphosarcoma in the cat: A report of nine cases. Journal of American Animal Hospital Association 1984; 20: 491-496.
8. Tobey JC, Houston DM and Breur GJ. Cutaneous T-cell lymphoma in a cat. Journal of American Veterinary Medical Association 1994; 204: 606-609.
9. Jackson ML, Wood SL, Misra V and Haines DM. Immunohistochemical identification of B and T lymphocytes in formalin-fixed, paraffin-embedded feline lymphosarcomas: Relation to feline leukemia virus status, tumor site, and patient age. Canadian Journal of Veterinary Research 1996; 60: 199-204.
10. Safran N, Perk K and Eyal O. Isolation of a novel retrovirus isolate from a leukaemic dog. Research in Veterinary Science 1992; 52: 250-255.
11. Ghernati I, Corbin A, Chabanne L, Auger C, Magnol JP, Fournel C, Monier JC, Darlix JL and Rigal D. Canine large granular lymphocyte leukemia and its derived cell line produce infectious retroviral particles. Veterinary Pathology 2000; 37: 310-317.
12. Ghosh SK, Abrams JT, Terunuma H, Vonderheid EC and Defreitas E. Human T-cell leukemia virus type I tax/rex DNA and RNA in cutaneous T-cell lymphoma. Blood 1994; 84: 2663-2671.
13. Pancake BA, Zucker-Franklin D and Coutavas EE. The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. Journal of Clinical Investigation 1995; 95: 547-554.
14. Trento E, Castilletti C, Ferraro C, Lesnoni LA, Parola I, Mussi A, Muscardin L, Bordignon V, D'Agosto G, Amantea A, Mastroianni A, Ameglio F, Fluhr J and Cordiali-Fei P. Human herpesvirus 8 infection in patients with cutaneous lymphoproliferative diseases. Archives of Dermatology 2005; 141: 1235-1242.
15. Ahmed N and Heslop HE. Viral lymphomagenesis. Current Opinion in Hematology 2006; 13: 254-259.
16. Lamberg SI and Bunn PA Jr. Cutaneous T-cell lymphomas. Summary of the Mycosis Fungoides Cooperative Group-National Cancer Institute. Workshop Archives of Dermatology 1979; 115: 1103-1105.
17. Weinstock MA and Horm JW. Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology. Journal of American Medical Association 1988; 260: 42-46.
18. Shapiro PE and Pinto FJ. The histologic spectrum of mycosis fungoides/ Sézary syndrome (Cutaneous T-cell lymphoma): A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. American Journal of Surgical Pathology 1994; 18: 645-667.
19. Mehrany K, Azhary R, Bouwhuis SA and Pittelkow MR. Cutaneous T-cell lymphoma and atopy: Is there an association? British Journal of Dermatology 2003; 149: 1013-1017.
20. Morrison WB. Cancer in Dogs and Cats, Medical and Surgical Management. 2nd edn., Jackson, WY, Teton NewMedia, 2001: 641-670.
21. Beale KM and Bolon B. Canine cutaneous lymphosarcoma epitheliotropic and non epitheliotropic, a retrospective study. In: Advances in Veterinary Dermatology, Vol. 2, PJ Ihrke, IS Mason and SD White, eds., New York, Pergamon Press, 1993: 273-284.
22. Poisson L, Olivry T and Lagourette P. Réticulose pagétoïde généralisée (forme Ketron-Goodman chez un chien. Pratique Médicale et Chirurgicale des Animaux de Compagnie 1996; 31: 219-225.
23. Foster AP, Evans E, Kerlin RL and Vail DM. Cutaneous T cell lymphoma with Sézary Syndrome in a dog. Veterinary Clinical Pathology 1997; 26: 188-192.
24. Bhang DH, Choi US, Kim MK, Choi EH, Kang MS, Hwang CY, Kim DY, Youn HY and Lee CW. Epitheliotropic cutaneous lymphoma (Mycosis fongoides) in a dog. Journal of Veterinary Science 2006; 7: 97-99.
25. Gilbert S, Clerckx C, Jauniaux T and Henroteaux M. Lymphome T cutanéépithéliotrome chez trois chiens. Annales de Médecine Vétérinaire 1994; 138: 587-595.
26. Day MJ. Immunophenotypic characterization of cutaneous lymphoid neoplasia in the dog and cat. Journal of Comparative Pathology 1995. 112: 79-96.
27. Santoro D, Marsalla R and Hernandez J. Investigation on the association between atopic dermatitis and the development of mycosis fungoides in dogs: A retrospective case-control study. Veterinary Dermatology 2007; 18: 101-106.
28. Kim EJ, Hess S, Richardson SK, Newton S, Showe LC, Benoit BM, Ubriani R, Vittorio CC, Junkins-Hopkins JM, Wysocka M and Rook AH. Immunopathogenesis and therapy of cutaneous T cell lymphoma. Journal of Clinical Investigation 2005; 115: 798-812.
29. Day MJ. Immune system neoplasia. In: Clinical Immunology of the Dog and Cat., London, Manson Publishing, 1999: 226-229.
30. Moore PF, Olivry T and Naydan D. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells. American Journal of Pathology 1994; 144: 421-429.
31. Nickoloff BJ and Griffiths CEM. Intraepidermal but not dermal T lymphocytes are positive for a cell-cycle-associated antigen (Ki67) in mycosis fongoides. American Journal of Pathology 1990; 136: 261-266.
32. Olivry T, Moore PF, Naydan DK, Danilenko DM and Affolter VK. Investigation of epidermotropism in canine mycosis fungoides: Expression of intercellular adhesion molecule-1 (ICAM-1) and beta-2 integrins. Archives in Dermatology Research 1995; 287: 186-192.
33. Edwards DS, Henley WE, Harding EF, Dobson JM and Wood JLN. Breed incidence of lymphoma in a UK population of insured dogs. Veterinary and Comparative Oncology 2003; 1: 200-206.
34. Fournel-Fleury C, Ponce F, Felman P, Blavier A, Bonnefont C, Chabanne L, Marchal T, Cadore JL, Goy-Thollot I, Ledieu D, Ghernati I and Magnol JP. Canine T-cell lymphomas: A morphological, immunological, and clinical study of 46 new cases. Veterinary Pathology 2002; 39: 92-109.
35. Magnol JP, Ghernati I, Marchal T, Chabane L and Delverdier A, Fournel C. Données cliniques, morphologiques et immunophénotypiques à partir de 10 observations de lymphome T cutanéo-muqueux épidermotrope du chien (analogue au Mycosis Fongoïde). Intérêt d'un modèle animal de pathologie spontanée. Bulletin de l'Académie Nationale de Médecine 1996; 180: 449-462.
36. Degorce F. Contibution à l'étude de l'analogue du Mycosis Fongoïde chez le chien: Revue bibliographique, etude histologique, ultrastructurale et immuno-histocimique. Thèse pour le doctorat vétérinaire, Paris, ENVAlfort, 1993.
37. Haghighi B, Smoller BR, Leboit PE, Warnke RA, Sander CA and Kohler S. Pagetoid reticulosis (Woringer-Kolopp disease): An immunophenotypic, molecular and clinicopathologic study. Modern Pathology 2000; 13: 502-510.
38. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, Van Vloten WA and Meijer CJ. Eortc classification for primary cutaneous lymphomas: A proposal from the Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354-371.
39. Withrow SJ and Macewen EG. Hematopoietic tumors. In: Small Animal Clinical Oncology, 3rd edn., Philadelphia, PA, W.B. Saunders Company, 2001: 558-584.
40. Murphy KM and Olivry T. Comparison of T-lymphocyte proliferation in canine epitheliotropic lymphosarcoma and benign lymphocytic dermatoses. Veterinary Dermatology 2000; 11: 99-105.
41. Willcock BP and Yager JA. The behaviour of epidermotropic lymphoma in twenty five-dogs. Canadian Veterinary Journal 1989; 30: 754-756.
42. Braun-Falco O, Marghescu S and Wolf MH. Pagetoid reticulose (Morbus Woringer-Kolopp). Der Hautarzt 1973; 24: 11-21.
43. Moore PF, Affolter VK, Olivry T and Schrenzel MD. The use of immunological reagents in defining the pathogenesis of canine skin diseases involving proliferation of leukocytes. In: Advances in Veterinary Dermatology, Vol. 3. KW Kwochka, T Willemse and C von Tscharner, eds., Oxford, Butterworth-Heinemann Press, 1996: 77-94.
44. Fournel-Fleury C, Magnol JP and Guelfi JF. Atlas en couleur de Cytologie du Cancer chez le Chien et le Chat. Paris, Conférence Nationale de Vétérinaires Spécialisés en Petits Animaux, 1994: 173; -212.
45. Knowles DM. Immunophenotypic and antigen receptor gene rearrangement analysis in T cell neoplasia. American Journal of Pathology 1989; 134: 761-785.
46. Mieke V, Wolf HH, Winzer M and Sterry W. Localized and disseminated pagetoid reticulosis: Diagnostic immunophenotypical findings. Archives in Dermatology 1989; 125: 402-406.
47. Berti E, Cerri A, Cavicchini S, Delia D, Soligo D, Alessi E and Caputo R. Primary cutaneous gamma/delta T-cell lymphoma presenting as disseminated pagetoid reticulosis. Journal of Investigative Dermatology 1991; 96: 718-723.
48. Seigneurin D and Guillaud P. Ki-67 antigen, a cell cycle and tumor growth marker. Pathologie Biologie (Paris) 1991; 39: 1020-1028.
49. Gerdes J, Dallenbach F and Lennert K. Growth fractions in malignant non-hodgkin's lymphomas as determined in situ with monoclonal antibody Ki 67. Hematological Oncology 1984; 2: 365-371.
50. Fournel-Fleury C, Magnol JP, Chabanne T, Ghernati I, Marchal T, Bonnefond C, Bryon PA and Felman P. Growth fractions in canine non-hodgkin's lymphomas as determined in situ by the expression of the Ki67-antigen. Journal of Comparative Pathology 1997; 117: 61-72.
51. Fung MA, Murphy MJ, Hoss DM and Grant-Kels JM. Practical evaluation and management of cutaneous lymphoma. Journal of American Academy of Dermatology 2002; 46: 325-354.
52. Momoi Y, Nagase M, Okamoto Y, Okuda M, Sasaki N, Watari T, Goitsuka R, Tsujimoto H and Hasegawa A. Rearrangements of immunoglobulin and T-cell receptor genes in canine lymphoma/leukemia cells. Journal of Veterinary Medical Science 1993; 55: 775-780.
53. Fivenson DP, Saed GM, Beck ER, Dunstan RW and Moore PFT. T-cell receptor gene rearrangement in canine mycosis fungoides: Further support for a canine model of cutaneous T-cell lymphoma. Journal of Investigative Dermatology 1994; 102: 227-230.
54. Vernau W and Moore PF. An immunophenotypic study of canine leukemias and preliminary assessment of clonality by polymerase chain reaction. Veterinary Immunology and Immunopathology 1999; 69: 145-164.
55. Dreitz MJ, Ogilvie G and Sim GK. Rearranged T lymphocyte antigen receptor genes as markers of malignant T cells. Veterinary Immunology and Immunopathology 1999; 69: 113-119.
56. Burnett RC, Vernau W, Modiano JF, Olver CS, Moore PF and Avery AC. Diagnosis of canine lymphoid neoplasia using clonal rearrangements of antigen receptor genes. Veterinary Pathology 2003; 40: 32-41.
57. Wilkerson MJ, Dolce K, Koopman T, Shuman W, Chun R, Garrett L, Barber L and Avery A. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules. Veterinary Immunology and Immunopathology 2005; 106: 179-196.
58. Fink-Puches R, Zenahlik P, Bäck B, Smolle J, Kerl H and Cerroni L. Primary cutaneous lymphomas: Applicability of current classification schemes (European Organization for Research and Treatment of Cancer-EORTC, World health organization WHO) based on clinicopathologic features observed in a large group of patients. Blood 2002; 99: 800-805.
59. De Lorimier LP. Updates on the management of canine epitheliotropic cutaneous T-cell lymphoma. Veterinary Clinics of North America: Small Animal Practice 2006; 36: 213-228.
60. Iwamoto KS, Bennett LR, Norman A, Villalobos AE and Hutson CA. Linoleate produces remission in canine mycosis fungoides. Cancer Letters 1992; 64: 17-22.
61. Risbon RE, De Lorimier LP, Skorupski K, Burgess KE, Bergman PJ, Carreras J, Hahn K, Leblanc A, Turek M, Impellizeri J, Fred R, Wojcieszyn JW, Drobatz K and Clifford CA. Response of canine cutaneous epitheliotropic lymphoma to lomustine (CCNU): A retrospective study of 46 cases (1999-2004). Journal of Veterinary Internal Medicine 2006; 20: 1389-1397.
62. Moore AS, London CA, Wood CA, Williams LE, Cotter SM, L'Heureux DA and Frimberger AE. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs. Journal of Veterinary Internal Medicine 1999; 13: 395-398.
63. Williams LE, Rassnick KM, Power HT, Lana SE, Morrison-Collister KE, Hansen K and Johnson JL. CCNU in the treatment of canine epitheliotropic lymphoma. Journal of Veterinary Internal Medicine 2006; 20: 136-143.
64. Zackheim HS, Kashani-Sabet M and Amin S. Topical corticosteroids for mycosis fungoides. Experience in 79 patients. Archives of Dermatology 1998; 134: 949-954.
65. Herrmann JJ, Roenigk HH Jr, Hurria A, Kuzel TM, Samuelson E, Rademaker AW and Rosen ST. Treatment of mycosis fungoides with photochemotherapy (PUVA): Long term follow-up. Journal of the American Academy of Dermatology 1995; 33: 234.
66. Willemze R. Cutaneous T cell lymphoma. In: Dermatology. JL Bolognia, JL Jorrizo and RP Rapini, eds., London, Mosby, 2003: 1921-1941.
67. Antalak JA, Cundiff JH and Ha CS. Utilization of thermoluminescent dosimetry in total skin electron beam radiotherapy of mycosis fungoides. International Journal of Radiation Oncology, Biology, Physics 1998; 40: 101-108.